Literature DB >> 9716567

Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle.

F Raga1, E M Casañ, J S Kruessel, Y Wen, H Y Huang, C Nezhat, M L Polan.   

Abstract

GnRH is one of the paracrine/autocrine regulators of hCG secretion produced by the human trophoblast during pregnancy. We hypothesized that GnRH may play a role in the embryonic/endometrial dialogue during early implantation. To examine this hypothesis, we assessed GnRH and GnRH-receptor mRNA and protein expression in human endometrium throughout the menstrual cycle of premenopausal fertile patients. Quantitation of the mRNA was performed by reverse transcription (RT)-competitive polymerase chain reaction (PCR) in the presence of a competitive cDNA fragment. RT-PCR revealed that unfractioned endometrium and isolated endometrial stromal and epithelial cells express GnRH and GnRH-receptor mRNA throughout all phases of the menstrual cycle. Quantitative PCR showed a dynamic pattern in the GnRH mRNA expression throughout the cycle, with a significant increase (p < 0.05) in the secretory phase as compared to the proliferative phase. Furthermore, quantitative competitive PCR of isolated glandular and stromal cells showed higher mRNA levels (p < 0.05) in the luteal phase in both compartments. GnRH immunostaining was localized in all major compartments, with the most intense staining during the luteal phase. On the basis of these data, we suggest that during reproductive life, endometrial GnRH may play a paracrine/autocrine role in the early stages of implantation by modulating embryonic trophoblastic secretion of hCG.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716567     DOI: 10.1095/biolreprod59.3.661

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  19 in total

1.  Gonadotropin-releasing hormone messenger ribonucleic acid and protein expression in Vero cells.

Authors:  H Y Huang; F Raga; J S Kruessel; Y Wen; Y K Soong; M L Polan
Journal:  J Assist Reprod Genet       Date:  2001-05       Impact factor: 3.412

2.  Epidermal growth factor influenced by opioid peptides in immature rat uterus.

Authors:  Z Vértes; A Sándor; K A Kovács; A Oszter; J L Környei; S Kovács; M Vértes
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

3.  The effects of GnRH antagonist on the endometrium of normally menstruating women.

Authors:  Porntip Sirayapiwat; Somchai Suwajanakorn; Surang Triratanachat; Somchai Niruthisard
Journal:  J Assist Reprod Genet       Date:  2007-11-30       Impact factor: 3.412

Review 4.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

5.  Association of controlled ovarian hyperstimulation treatment with down-regulation of key regulators involved in embryonic implantation in mice.

Authors:  Min Xiong; Hanwang Zhang; Lei Jin; Jihui Ai; Zhiyong Huang; Guijin Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

6.  Artificial Cycle with or without a Depot Gonadotropin-releasing Hormone Agonist for Frozen-thawed Embryo Transfer: An Assessment of Infertility Type that Is Most Suitable.

Authors:  Di Xie; Fan Chen; Shou-Zhen Xie; Zhi-Lan Chen; Ping Tuo; Rong Zhou; Juan Zhang
Journal:  Curr Med Sci       Date:  2018-08-20

7.  The LH/hCG Axis in Endometrial Cancer: A New Target in the Treatment of Recurrent or Metastatic Disease.

Authors:  A Arcangeli; I Noci; A Fortunato; G F Scarselli
Journal:  Obstet Gynecol Int       Date:  2010-07-15

Review 8.  Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.

Authors:  João Batista A Oliveira; Ricardo Baruffi; Cláudia G Petersen; Ana L Mauri; Mario Cavagna; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2010-09-08       Impact factor: 5.211

9.  Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes.

Authors:  Laura Detti; Dana R Ambler; Frank D Yelian; Michael L Kruger; Michael P Diamond; Elizabeth E Puscheck
Journal:  J Assist Reprod Genet       Date:  2008-05-07       Impact factor: 3.412

10.  Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol.

Authors:  Dan Zhang; Mi Han; Mingjuan Zhou; Mengyu Liu; Yan Li; Bufang Xu; Aijun Zhang
Journal:  Reprod Biol Endocrinol       Date:  2021-07-02       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.